Suchergebnisse - "Ferrari, Serge"

PubPharm (18)

1

Response to Letter to the Editor : "Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment"

enthalten in: The Journal of clinical endocrinology and metabolism | 2019

von Ferrari, S.

CommentOn: J Clin Endocrinol Metab. 2019 Aug 1;104(8):3450-3461. - PMID 31125092

2

Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis

enthalten in: Advances in therapy | 2019

von Lorentzon, M. | Branco, J. | Brandi, M. | +22

3

Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment

enthalten in: The Journal of clinical endocrinology and metabolism | 2019

von Ferrari, S. | Butler, P. | Kendler, D. | +6

CommentIn: J Clin Endocrinol Metab. 2019 Dec 1;104(12):5806. - PMID 31290968

4

enthalten in: Revue medicale suisse | 2018

von Uebelhart, B. | Ferrari, S.

5

Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study

enthalten in: BMC musculoskeletal disorders | 2017

von Adachi, J. | Bone, H. | Daizadeh, N. | +9

6

enthalten in: Revue medicale suisse | 2017

von Ferrari, S. | Lamy, O.

7

To where and until when handle the osteoporosis?

enthalten in: Revue medicale suisse | 2017

von Uebelhart, B. | Ferrari, S.

8

enthalten in: Revue medicale suisse | 2017

von Uebelhart, B. | Ferrari, S.

9

Osteoporosis drug treatment : duration and management after discontinuation. A position statement from the SVGO/ASCO

enthalten in: Swiss medical weekly | 2017

von Meier, C. | Uebelhart, B. | Aubry-Rozier, B. | +9

10

Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture

enthalten in: Archives of osteoporosis | 2016

von Ferrari, S. | Reginster, J. | Brandi, M. | +6

ErratumIn: Arch Osteoporos. 2017 Dec;12 (1):25. - PMID 28255680